Finance

Beta
Lists
RZLT:NASDAQ
Rezolute Inc
$4.91
-0.81%
(-0.040) 1D
$4.80
-2.24% (-0.11)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RZLT...
Open
$4.99
High
$5.06
Low
$4.84
Mkt. cap
472.80M
Avg. vol.
2.28M
Volume
2.79M
52-wk high
$11.46
52-wk low
$1.07
EPS
-$0.81
Beta
0.54
Shares outstanding
96.29M
No. of employees
68
Open
$4.99
High
$5.06
Low
$4.84
Mkt. cap
472.80M
Avg. vol.
2.28M
Volume
2.79M
52-wk high
$11.46
52-wk low
$1.07
EPS
-$0.81
Beta
0.54
Shares outstanding
96.29M
No. of employees
68
News stories
From sources across the web
About Rezolute Inc
CEO-
Employees68
Founded2010
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websiterezolutebio.com
Analyst ratings
Based on 8 analysts giving stock ratings to RZLT in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for RZLT in the last 3 months.
Highest
Current $4.91
$14.00 (+185.13%)
Average
$8.43 (+71.69%)
Lowest
$5.00 (+1.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Buy
Reiterated
$11.00
+124%
06/15/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$5.00
+1.8%
06/15/2026
Jason Butler
Citizens JMP
Buy
Upgraded
$11.00
+124%
06/03/2026
Julian Harrison
BTIG
Buy
Maintained
$6.00
+22.2%
06/02/2026
Yun Zhong
Wedbush
Buy
Reiterated
$6.00
+22.2%
06/03/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$14.00
+185.1%
06/03/2026
Matt Hewitt
Craig-Hallum
Hold
Maintained
-
-
06/02/2026
Catherine Novack
JonesTrading
Buy
Reiterated
$6.00
+22.2%
06/02/2026
Pete Stavropoulos
Cantor Fitzgerald
Hold
Maintained
-
-
03/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.73M
13.03M
13.33M
10.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.12M
6.79M
9.39M
5.48M
Operating expense
25.85M
19.82M
22.72M
15.87M
Total operating expenses
25.85M
19.82M
22.72M
15.87M
Operating income
-25.85M
-19.82M
-22.72M
-15.87M
Other non operating income
15.00K
-15.00K
-
-
EBT including unusual items
-24.39M
-18.15M
-22.77M
-16.17M
EBT excluding unusual items
-24.39M
-18.15M
-21.27M
-14.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24.39M
-18.15M
-22.77M
-16.17M
Net profit margin
-
-
-
-
Earnings per share
-0.26
-0.18
-0.22
-0.16
Interest and investment income
1.44M
1.68M
1.45M
1.20M
Interest expense
-
-
-
-
Net interest expenses
1.44M
1.68M
1.45M
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.84M
-19.81M
-22.71M
-15.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer